Table 2

Clinical and pathological characteristics in 50 patients with ovarian carcinoma

Serous papillary adenocarcinomaClear cell adenocarcinoma
F/I/UaMRP1 high/low(n = 20)
(n = 11/11/8)(n = 15/15)
Age (yrs)P = 0.34P = 0.71
≤536 /3/58 /74
>535 /8/37 /816
FIGO stagebP = 0.34P = 0.68
I0 /0/00 /014
II0 /0/00 /01
III10 /7/512 /105
IV1 /4/33 /50
GradeP = 0.52P = 0.71
G10 /0/00 /016
G26 /3/35 /73
G35 /8/510 /81
Residual lesionP = 1.00P = 0.71
≤2 cm5 /4/35 /719
>2 cm6 /7/510 /81
Chemo-regimencP = 0.18P = 0.17
CDDP/Epi/Cyclo7 /9/814 /100
CBDCA/paclitaxel4 /2/01 /50
CDDP/CPT-110 /0/00 /020
  • a F/I/U, favorable/intermediate/unfavorable.

  • b FIGO, International Federation of Obstetrics and Gynecology.

  • c CDDP, cisplatin; Epi, epirubicin; Cyclo, cyclophosphamide.